IMPORTANCE: Since the 1980s, pancreas transplant has become the most effective treatment strategy to restore euglycemia in patients with type 1 diabetes mellitus. However, technical complications and BK virus nephropathy continue to be important causes of early and late graft loss. These and other complications lead to cited 1- and 3-year graft survival rates of 74% and 67% (pancreas) and 81% and 73% (kidney). OBJECTIVE: To examine our center's outcomes with pancreas-kidney transplant and early BK virus screening and treatment. DESIGN: Prospective study from August 2004 to January 2012. SETTING: University medical center. PARTICIPANTS: Sixty-five patients with type 1 diabetes who underwent simultaneous kidney and pancreas, pancreas after kidney, or pancreas transplant alone at a single center. INTERVENTION: Pancreas transplant. MAIN OUTCOME MEASURES: Pancreas and kidney survival; patient survival; and kidney loss due to BK virus nephropathy. RESULTS: Patient survival at 1, 3, and 5 years was 100%, 98.4%, and 98.4%, respectively. Of 2 early pancreatic allograft losses, 1 was due to thrombosis (1.6%). One- and 5-year pancreas graft survival rates were 95.4% and 92.3%; losses after more than 1 year were due to rejection. Kidney survival rates were 100% and 95.2% at 1 and 5 years; losses were due to nephropathy and noncompliance, with 1 death with function. BK virus incidence was 29.2%, with no graft losses due to BK infection. CONCLUSIONS AND RELEVANCE: While pancreas transplant can be complicated by early graft loss, our results suggest that excellent outcomes at 5 years can be achieved. Posttransplant BK virus screening and treatment are essential tools to long-term success.
IMPORTANCE: Since the 1980s, pancreas transplant has become the most effective treatment strategy to restore euglycemia in patients with type 1 diabetes mellitus. However, technical complications and BK virus nephropathy continue to be important causes of early and late graft loss. These and other complications lead to cited 1- and 3-year graft survival rates of 74% and 67% (pancreas) and 81% and 73% (kidney). OBJECTIVE: To examine our center's outcomes with pancreas-kidney transplant and early BK virus screening and treatment. DESIGN: Prospective study from August 2004 to January 2012. SETTING: University medical center. PARTICIPANTS: Sixty-five patients with type 1 diabetes who underwent simultaneous kidney and pancreas, pancreas after kidney, or pancreas transplant alone at a single center. INTERVENTION: Pancreas transplant. MAIN OUTCOME MEASURES: Pancreas and kidney survival; patient survival; and kidney loss due to BK virus nephropathy. RESULTS:Patient survival at 1, 3, and 5 years was 100%, 98.4%, and 98.4%, respectively. Of 2 early pancreatic allograft losses, 1 was due to thrombosis (1.6%). One- and 5-year pancreas graft survival rates were 95.4% and 92.3%; losses after more than 1 year were due to rejection. Kidney survival rates were 100% and 95.2% at 1 and 5 years; losses were due to nephropathy and noncompliance, with 1 death with function. BK virus incidence was 29.2%, with no graft losses due to BK infection. CONCLUSIONS AND RELEVANCE: While pancreas transplant can be complicated by early graft loss, our results suggest that excellent outcomes at 5 years can be achieved. Posttransplant BK virus screening and treatment are essential tools to long-term success.
Authors: Claudia Bösmüller; Franka Messner; Christian Margreiter; Michael Rudnicki; Robert Öllinger; Dietmar Öfner; Stefan Schneeberger; Manuel Maglione Journal: Transplant Direct Date: 2017-04-13
Authors: Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas Journal: World J Transplant Date: 2016-09-24